Many expensive new drugs are expected to hit the shelves in 2016, a year in which lawmakers are ramping up attention on the steep cost of treatments for some major diseases. The top eight new drugs treating serious illnesses, from cancer to HIV to multiple sclerosis, are projected to generate $16.6 billion in sales four years from now, after they’ve been on the market for a while, according Wall Street analysts at EP Vantage.